Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone in elderly patients with chronic constipation
ChiCTR2400091522Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cobiprostone in chronic constipation and functional constipation (FC), sponsored by Peking University People's Hospital. Primary endpoint: Frequency of spontaneous bowel movements during week 1. Started Oct 2024; status: recruiting.
02
Drugs
cobiprostone
03
Conditions
chronic constipationfunctional constipation (FC)
Beyond the preview
Go deeper on ChiCTR2400091522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091522.